Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
This is a real world study aiming to observe the efficacy and safety of Anlotinib capsules in
patients with advanced medullary thyroid carcinoma, and to summarize the treatment experience
in a broad population of patients.